Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

[1]  L. Dawson,et al.  ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy , 2020, American journal of clinical oncology.

[2]  R. Werner,et al.  Technological quality requirements for stereotactic radiotherapy , 2020, Strahlentherapie und Onkologie.

[3]  Oliver Blanck,et al.  ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams , 2019, Strahlentherapie und Onkologie.

[4]  Matthias Guckenberger,et al.  ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  T. Brunner,et al.  Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer , 2016, Strahlentherapie und Onkologie.

[6]  K. Herfarth,et al.  Stereotactic body radiotherapy for liver tumors , 2014, Strahlentherapie und Onkologie.

[7]  M. Ruge,et al.  Stereotactic radiosurgery for treatment of brain metastases , 2014, Strahlentherapie und Onkologie.

[8]  Kocher,et al.  Stereotactic radiosurgery for treatment of brain metastases , 2014, Strahlentherapie und Onkologie.

[9]  O. Sauer,et al.  Definition of stereotactic body radiotherapy , 2013, Strahlentherapie und Onkologie.